AR123800A1 - Composiciones de relleno para liberación sostenida y cápsulas que las contienen - Google Patents

Composiciones de relleno para liberación sostenida y cápsulas que las contienen

Info

Publication number
AR123800A1
AR123800A1 ARP210102851A ARP210102851A AR123800A1 AR 123800 A1 AR123800 A1 AR 123800A1 AR P210102851 A ARP210102851 A AR P210102851A AR P210102851 A ARP210102851 A AR P210102851A AR 123800 A1 AR123800 A1 AR 123800A1
Authority
AR
Argentina
Prior art keywords
daltons
sustained release
capsule
weight
composition
Prior art date
Application number
ARP210102851A
Other languages
English (en)
Spanish (es)
Inventor
Qi Fang
Karunakar Sukuru
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of AR123800A1 publication Critical patent/AR123800A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP210102851A 2020-10-16 2021-10-15 Composiciones de relleno para liberación sostenida y cápsulas que las contienen AR123800A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063092679P 2020-10-16 2020-10-16

Publications (1)

Publication Number Publication Date
AR123800A1 true AR123800A1 (es) 2023-01-11

Family

ID=81209315

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210102851A AR123800A1 (es) 2020-10-16 2021-10-15 Composiciones de relleno para liberación sostenida y cápsulas que las contienen

Country Status (14)

Country Link
US (1) US20230372252A1 (enExample)
EP (1) EP4228608A4 (enExample)
JP (1) JP2023545494A (enExample)
KR (1) KR20230088730A (enExample)
CN (1) CN116367864A (enExample)
AR (1) AR123800A1 (enExample)
AU (2) AU2021360905B2 (enExample)
CA (1) CA3195386A1 (enExample)
CO (1) CO2023005368A2 (enExample)
IL (1) IL301692A (enExample)
MX (1) MX2023004441A (enExample)
NZ (1) NZ799086A (enExample)
TW (1) TW202228655A (enExample)
WO (1) WO2022081848A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240099982A1 (en) * 2022-09-27 2024-03-28 Gaia Herbs Cellulose derivative free capsule for herbal extracts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
PE20141171A1 (es) * 2011-10-06 2014-09-21 Gruenenthal Chemie Forma de dosificacion farmaceutica oral resistente a alteracion comprendiendo agonista opioide y antagonista opioide
US20150366814A1 (en) * 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
WO2016140933A2 (en) * 2015-03-02 2016-09-09 Bionpharma Healthcare Llc Immediate release soluble ibuprofen compositions
EP3285746A1 (en) * 2015-04-24 2018-02-28 Grünenthal GmbH Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a powder
WO2016170097A1 (en) * 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
US9943513B1 (en) * 2015-10-07 2018-04-17 Banner Life Sciences Llc Opioid abuse deterrent dosage forms
EP3856160A4 (en) * 2018-09-25 2022-07-06 SpecGx LLC ABUSE-PROOF IMMEDIATE RELEASE CAPSULE DOSAGE FORMS

Also Published As

Publication number Publication date
AU2026201700A1 (en) 2026-03-26
EP4228608A1 (en) 2023-08-23
TW202228655A (zh) 2022-08-01
AU2021360905B2 (en) 2026-01-08
AU2021360905A1 (en) 2023-06-01
KR20230088730A (ko) 2023-06-20
JP2023545494A (ja) 2023-10-30
NZ799086A (en) 2026-02-27
MX2023004441A (es) 2023-05-08
WO2022081848A1 (en) 2022-04-21
CO2023005368A2 (es) 2023-05-19
CN116367864A (zh) 2023-06-30
CA3195386A1 (en) 2022-04-21
AU2021360905A9 (en) 2024-10-10
IL301692A (en) 2023-05-01
EP4228608A4 (en) 2024-10-02
US20230372252A1 (en) 2023-11-23

Similar Documents

Publication Publication Date Title
ES2904826T3 (es) Composición de cemento endodóntico a base de mineral biomimético
ES2804779T3 (es) Cápsulas resistentes a los ácidos
ES2226418T5 (es) Composiciones para recubrimiento de almidon modificado.
AR123800A1 (es) Composiciones de relleno para liberación sostenida y cápsulas que las contienen
ES2206081T3 (es) Procedimiento para la preparacion de composiciones farmaceuticas para uso con formulaciones de gelatina blanda.
Rein et al. Meloxicam-loaded solvent exchange-induced in situ forming beta-cyclodextrin gel and microparticle for periodontal pocket delivery
PE20010801A1 (es) Dispositivos para el suministro de farmacos que tienen propiedades antiprogestinicas
HRP20201138T1 (hr) Stabilan farmaceutski sastav za ubrizgavanje antagonista neurokinin 1 receptora i postupak pripreme istoga
BRPI0517674B1 (pt) Sistema de cápsula mole de não-gelatina contendo amido modificado e carragenina com solução de enchimento de natureza básica
PE20040675A1 (es) Formulaciones de deposito de liberacion controlada
KR20120128602A (ko) 연질캡슐용 막 형성 조성물
CN1172642A (zh) 多相软明胶药物剂型
AR124044A1 (es) Cápsulas blandas de liberación retardada
CN102240277B (zh) 一种治疗牙周炎的药物组合物及其制备方法及应用
AR122316A1 (es) Formulaciones de cápsulas de gel blando de origen no animal, métodos de preparación y métodos de uso de estas
CN107375195A (zh) 一种基于壳聚糖的牙周局部药物缓释水凝胶及其应用
Tapsir et al. Sealing ability of various restorative materials as coronal barriers between endodontic appointments
ES2785382T3 (es) Liberación sostenida de bimatoprost, análogos de bimatoprost, prostamidas y prostaglandinas para la reducción de grasa
CN1172646A (zh) 含有抗气胀药的软明胶药物剂型的填充物质
ES2531669T3 (es) Composición acuosa estéril basada en alginato para uso médico y procedimiento para la preparación de la misma
Eftekhar et al. Evaluation of hydroxyl ion diffusion in dentin and injectable forms and a simple powder-water calcium hydroxide paste: An in vitro study
CN106075558A (zh) 一种宫腔损伤后保护修复材料及其制备方法
CO2023001954A2 (es) Cápsulas blandas de gelatina que incorporan formas de dosificación de liberación inmediata y extendida y métodos de fabricación
Arvapalli et al. A novel in-situ gel approach for sustained release of eplerenone
Chogle et al. Preliminary evaluation of a novel polymer nanocomposite as a root‐end filling material